Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Panwalker

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug Intelligence & Clinical Pharmacy|December 1, 1986
Serum sickness associated with cefoxitin and pentoxifylline therapyA P Panwalker, K Gibson, M J Glynn, et al.
Infection|January 1, 1977
Actinobacillus actinomycetemcomitans endocarditis in a patient with a prosthetic aortic valveA P Panwalker, H E Akalin, V Zimelis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1978
Netilmicin: clinical efficacy, tolerance, and toxicityA P Panwalker, J B Malow, V M Zimelis, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activityG M Trager, G W White, V M Zimelis, et al.
Chemotherapy|January 1, 1981
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazoneG M Trager, G W White, V M Zimelis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1979
Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycosideG W White, J B Malow, V M Zimelis, et al.
Chemotherapy|January 1, 1981
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiencyG M Trager, A P Panwalker, J B Malow, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug Intelligence & Clinical Pharmacy|December 1, 1986
Serum sickness associated with cefoxitin and pentoxifylline therapyA P Panwalker, K Gibson, M J Glynn, et al.
Infection|January 1, 1977
Actinobacillus actinomycetemcomitans endocarditis in a patient with a prosthetic aortic valveA P Panwalker, H E Akalin, V Zimelis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1978
Netilmicin: clinical efficacy, tolerance, and toxicityA P Panwalker, J B Malow, V M Zimelis, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activityG M Trager, G W White, V M Zimelis, et al.
Chemotherapy|January 1, 1981
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazoneG M Trager, G W White, V M Zimelis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1979
Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycosideG W White, J B Malow, V M Zimelis, et al.
Chemotherapy|January 1, 1981
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiencyG M Trager, A P Panwalker, J B Malow, et al.
Pageof 2